GlassScriptPhysician profile
Vijeth R Sringeri
NPI 1356371314
$1,947.91
in general payments reported to CMS, 2019-2025
37 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,027 · 2020: $116 · 2021: $124 · 2022: $228 · 2023: $414 · 2024: $39.42.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $454.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $453.50 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novartis Pharmaceuticals Corporation | $217.61 | 2019-2023 | |
| Astrazeneca Pharmaceuticals LP | $203.37 | 2019-2024 | Breztri |
| Pfizer INC. | $188.81 | 2019-2023 | |
| Bayer Healthcare Pharmaceuticals INC. | $135.64 | 2022-2023 | |
| Glaxosmithkline, LLC. | $126.70 | 2019 | |
| Janssen Pharmaceuticals, INC | $112.01 | 2019-2023 | Xarelto |
| Boston Scientific Corporation | $104.97 | 2021 | |
| Abbvie INC. | $91.53 | 2019-2023 | Ubrelvy, Vraylar |
| Biohaven Pharmaceutical Holding Company LTD. | $75.22 | 2022 | |
| Novo Nordisk INC | $65.51 | 2019-2023 | Ozempic, Rybelsus |
| Boehringer Ingelheim Pharmaceuticals, INC. | $55.34 | 2019-2020 | |
| Scilex Pharmaceuticals INC. | $44.36 | 2019 | |
| Sunovion Pharmaceuticals INC. | $34.44 | 2019 | |
| Amarin Pharma, INC. | $33.41 | 2019-2020 | |
| Otsuka America Pharmaceutical, INC. | $32.62 | 2019-2023 | Rexulti |
Show all 37 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Amgen INC. | $30.58 | 2023 | Repatha, Otezla |
| Lilly USA, LLC | $29.92 | 2020-2023 | Jardiance, Emgality |
| Sanofi-Aventis U.S. LLC | $29.68 | 2019-2020 | |
| Nestle Healthcare Nutrition INC. | $29.23 | 2023 | |
| Merck Sharp & Dohme LLC | $27.47 | 2019 | |
| Astellas Pharma US INC | $24.64 | 2019 | |
| Exact Sciences Corporation | $23.01 | 2023 | Cologuard Collection Kit |
| Jazz Pharmaceuticals INC. | $20.10 | 2019 | |
| Dexcom, INC. | $20.00 | 2023 | Dexcom G6 Transmitter |
| Xeris Pharmaceuticals, INC. | $19.69 | 2023 | Gvoke Hypopen |
| Allergan, INC. | $19.14 | 2019 | |
| Biohaven Pharmaceuticals, INC. | $18.78 | 2021 | |
| Sanofi Pasteur INC. | $18.15 | 2023 | |
| Axsome Therapeutics, INC. | $15.90 | 2023 | Sunosi |
| Abbott Laboratories | $15.34 | 2023 | Eterna |
| Indivior INC. | $14.30 | 2023 | Perseris |
| Idorsia Pharmaceuticals US INC | $13.61 | 2023 | Quviviq |
| Teva Pharmaceuticals USA, INC. | $11.55 | 2019 | |
| Arbor Pharmaceuticals, INC. | $11.39 | 2019 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $11.39 | 2019 | |
| Avanir Pharmaceuticals, INC. | $11.32 | 2019 | |
| Mylan Specialty L.P. | $11.18 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Vijeth Sringeri listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.